nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—multiple sclerosis—amyotrophic lateral sclerosis	0.869	1	CtDrD
Fingolimod—CYP4F2—tongue—amyotrophic lateral sclerosis	0.00647	0.195	CbGeAlD
Fingolimod—Traumatic liver injury—Riluzole—amyotrophic lateral sclerosis	0.00365	0.0976	CcSEcCtD
Fingolimod—Lymphopenia—Riluzole—amyotrophic lateral sclerosis	0.00266	0.0711	CcSEcCtD
Fingolimod—Cerebral haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00246	0.0657	CcSEcCtD
Fingolimod—S1PR1—brainstem—amyotrophic lateral sclerosis	0.00222	0.0668	CbGeAlD
Fingolimod—Gamma-glutamyltransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00165	0.0442	CcSEcCtD
Fingolimod—Liver injury—Riluzole—amyotrophic lateral sclerosis	0.00162	0.0432	CcSEcCtD
Fingolimod—S1PR5—nervous system—amyotrophic lateral sclerosis	0.00159	0.0478	CbGeAlD
Fingolimod—S1PR5—central nervous system—amyotrophic lateral sclerosis	0.00153	0.046	CbGeAlD
Fingolimod—S1PR5—cerebellum—amyotrophic lateral sclerosis	0.0015	0.045	CbGeAlD
Fingolimod—CYP4F12—medulla oblongata—amyotrophic lateral sclerosis	0.00147	0.0443	CbGeAlD
Fingolimod—S1PR1—spinal cord—amyotrophic lateral sclerosis	0.00138	0.0416	CbGeAlD
Fingolimod—S1PR3—nervous system—amyotrophic lateral sclerosis	0.00132	0.0397	CbGeAlD
Fingolimod—CYP4F12—spinal cord—amyotrophic lateral sclerosis	0.00131	0.0395	CbGeAlD
Fingolimod—S1PR3—central nervous system—amyotrophic lateral sclerosis	0.00127	0.0382	CbGeAlD
Fingolimod—S1PR5—brain—amyotrophic lateral sclerosis	0.00122	0.0365	CbGeAlD
Fingolimod—S1PR1—nervous system—amyotrophic lateral sclerosis	0.00116	0.035	CbGeAlD
Fingolimod—SPHK1—nervous system—amyotrophic lateral sclerosis	0.00115	0.0346	CbGeAlD
Fingolimod—S1PR1—central nervous system—amyotrophic lateral sclerosis	0.00112	0.0337	CbGeAlD
Fingolimod—Eczema—Riluzole—amyotrophic lateral sclerosis	0.0011	0.0294	CcSEcCtD
Fingolimod—S1PR1—cerebellum—amyotrophic lateral sclerosis	0.0011	0.033	CbGeAlD
Fingolimod—CYP4F12—cerebellum—amyotrophic lateral sclerosis	0.00104	0.0313	CbGeAlD
Fingolimod—S1PR3—brain—amyotrophic lateral sclerosis	0.00101	0.0304	CbGeAlD
Fingolimod—Migraine—Riluzole—amyotrophic lateral sclerosis	0.000973	0.026	CcSEcCtD
Fingolimod—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00094	0.0251	CcSEcCtD
Fingolimod—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.000912	0.0244	CcSEcCtD
Fingolimod—S1PR1—brain—amyotrophic lateral sclerosis	0.00089	0.0268	CbGeAlD
Fingolimod—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00089	0.0238	CcSEcCtD
Fingolimod—SPHK1—brain—amyotrophic lateral sclerosis	0.000881	0.0265	CbGeAlD
Fingolimod—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.000872	0.0233	CcSEcCtD
Fingolimod—Influenza—Riluzole—amyotrophic lateral sclerosis	0.000854	0.0228	CcSEcCtD
Fingolimod—CYP4F12—brain—amyotrophic lateral sclerosis	0.000846	0.0254	CbGeAlD
Fingolimod—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.000821	0.0219	CcSEcCtD
Fingolimod—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.000773	0.0206	CcSEcCtD
Fingolimod—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.000766	0.0205	CcSEcCtD
Fingolimod—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.000762	0.0203	CcSEcCtD
Fingolimod—Infestation—Riluzole—amyotrophic lateral sclerosis	0.000762	0.0203	CcSEcCtD
Fingolimod—Depression—Riluzole—amyotrophic lateral sclerosis	0.000759	0.0203	CcSEcCtD
Fingolimod—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.000715	0.0191	CcSEcCtD
Fingolimod—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.000696	0.0186	CcSEcCtD
Fingolimod—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.000672	0.0179	CcSEcCtD
Fingolimod—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.000639	0.0171	CcSEcCtD
Fingolimod—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.000635	0.0169	CcSEcCtD
Fingolimod—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00062	0.0166	CcSEcCtD
Fingolimod—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000616	0.0165	CcSEcCtD
Fingolimod—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.000604	0.0161	CcSEcCtD
Fingolimod—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.000599	0.016	CcSEcCtD
Fingolimod—Back pain—Riluzole—amyotrophic lateral sclerosis	0.000576	0.0154	CcSEcCtD
Fingolimod—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.000533	0.0142	CcSEcCtD
Fingolimod—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.000526	0.014	CcSEcCtD
Fingolimod—Cough—Riluzole—amyotrophic lateral sclerosis	0.000519	0.0139	CcSEcCtD
Fingolimod—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000514	0.0137	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.000503	0.0134	CcSEcCtD
Fingolimod—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.000492	0.0148	CbGeAlD
Fingolimod—Infection—Riluzole—amyotrophic lateral sclerosis	0.000483	0.0129	CcSEcCtD
Fingolimod—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000476	0.0127	CcSEcCtD
Fingolimod—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000472	0.0126	CcSEcCtD
Fingolimod—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000454	0.0121	CcSEcCtD
Fingolimod—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000436	0.0117	CcSEcCtD
Fingolimod—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000433	0.0116	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000419	0.0112	CcSEcCtD
Fingolimod—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000419	0.0112	CcSEcCtD
Fingolimod—SPHK1—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.00035	0.00585	CbGpPWpGaD
Fingolimod—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000349	0.00931	CcSEcCtD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000345	0.00575	CbGpPWpGaD
Fingolimod—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000344	0.00918	CcSEcCtD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.000338	0.00564	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.000338	0.00564	CbGpPWpGaD
Fingolimod—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000333	0.00556	CbGpPWpGaD
Fingolimod—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000332	0.00888	CcSEcCtD
Fingolimod—CYP2D6—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.000329	0.00549	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000324	0.00541	CbGpPWpGaD
Fingolimod—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000321	0.00858	CcSEcCtD
Fingolimod—SPHK1—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.00032	0.00535	CbGpPWpGaD
Fingolimod—CYP4F12—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000318	0.0053	CbGpPWpGaD
Fingolimod—S1PR1—PDGFR-beta signaling pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000316	0.00527	CbGpPWpGaD
Fingolimod—CYP4F12—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000313	0.00523	CbGpPWpGaD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.000307	0.00512	CbGpPWpGaD
Fingolimod—Headache—Riluzole—amyotrophic lateral sclerosis	0.000304	0.00813	CcSEcCtD
Fingolimod—SPHK1—Beta3 integrin cell surface interactions—VEGFA—amyotrophic lateral sclerosis	0.000292	0.00486	CbGpPWpGaD
Fingolimod—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.000282	0.00848	CbGeAlD
Fingolimod—SPHK1—PDGFR-beta signaling pathway—PLA2G4A—amyotrophic lateral sclerosis	0.00028	0.00466	CbGpPWpGaD
Fingolimod—CYP2E1—Vitamin A and Carotenoid Metabolism—RARA—amyotrophic lateral sclerosis	0.000276	0.00461	CbGpPWpGaD
Fingolimod—CYP4F2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000274	0.00458	CbGpPWpGaD
Fingolimod—CYP4F2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000271	0.00451	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000267	0.00446	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.000266	0.00443	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000259	0.00431	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000257	0.00429	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000257	0.00429	CbGpPWpGaD
Fingolimod—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.000248	0.00747	CbGeAlD
Fingolimod—CYP4F12—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000243	0.00406	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000243	0.00406	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000234	0.0039	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000223	0.00372	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000222	0.00371	CbGpPWpGaD
Fingolimod—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.000222	0.00666	CbGeAlD
Fingolimod—SPHK1—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.000219	0.00365	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00021	0.00351	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00021	0.00351	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000207	0.00345	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000196	0.00327	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000195	0.00325	CbGpPWpGaD
Fingolimod—S1PR4—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.000193	0.00322	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000192	0.00321	CbGpPWpGaD
Fingolimod—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.000187	0.00561	CbGeAlD
Fingolimod—S1PR5—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.000186	0.0031	CbGpPWpGaD
Fingolimod—S1PR3—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.000186	0.0031	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.000184	0.00307	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000181	0.00301	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000181	0.00301	CbGpPWpGaD
Fingolimod—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.00018	0.0054	CbGeAlD
Fingolimod—CYP4F2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000179	0.00298	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—DAO—amyotrophic lateral sclerosis	0.000176	0.00294	CbGpPWpGaD
Fingolimod—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.000176	0.00528	CbGeAlD
Fingolimod—S1PR1—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.000168	0.00281	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000168	0.00281	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000168	0.0028	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000165	0.00276	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.000156	0.00261	CbGpPWpGaD
Fingolimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000155	0.00258	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000154	0.00256	CbGpPWpGaD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000153	0.00256	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—DAO—amyotrophic lateral sclerosis	0.000152	0.00254	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000151	0.00252	CbGpPWpGaD
Fingolimod—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.00015	0.00452	CbGeAlD
Fingolimod—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000148	0.00444	CbGeAlD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000148	0.00246	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000148	0.00246	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000145	0.00243	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000145	0.00243	CbGpPWpGaD
Fingolimod—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000145	0.00435	CbGeAlD
Fingolimod—SPHK1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000144	0.00241	CbGpPWpGaD
Fingolimod—CYP2E1—brain—amyotrophic lateral sclerosis	0.000143	0.00429	CbGeAlD
Fingolimod—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000142	0.00428	CbGeAlD
Fingolimod—SPHK1—VEGFA-VEGFR2 Pathway—VEGFA—amyotrophic lateral sclerosis	0.000141	0.00235	CbGpPWpGaD
Fingolimod—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000139	0.00418	CbGeAlD
Fingolimod—S1PR4—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000137	0.00229	CbGpPWpGaD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000134	0.00223	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000133	0.00223	CbGpPWpGaD
Fingolimod—SPHK1—Signaling by VEGF—VEGFA—amyotrophic lateral sclerosis	0.000133	0.00221	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000132	0.0022	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000132	0.0022	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000132	0.0022	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000131	0.00218	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—GSR—amyotrophic lateral sclerosis	0.000123	0.00205	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.00012	0.002	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000117	0.00195	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.000116	0.00193	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000115	0.00192	CbGpPWpGaD
Fingolimod—CYP2D6—brain—amyotrophic lateral sclerosis	0.000113	0.0034	CbGeAlD
Fingolimod—S1PR3—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000112	0.00187	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000112	0.00187	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000107	0.00178	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—GSR—amyotrophic lateral sclerosis	0.000106	0.00177	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000103	0.00172	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000103	0.00172	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000102	0.0017	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000101	0.00169	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000101	0.00168	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PLB1—amyotrophic lateral sclerosis	9.89e-05	0.00165	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	9.68e-05	0.00161	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	9.68e-05	0.00161	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	9.68e-05	0.00161	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—VCP—amyotrophic lateral sclerosis	9.53e-05	0.00159	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	9.35e-05	0.00156	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	9.23e-05	0.00154	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—VCP—amyotrophic lateral sclerosis	9.18e-05	0.00153	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—VCP—amyotrophic lateral sclerosis	9.18e-05	0.00153	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—GSR—amyotrophic lateral sclerosis	9.13e-05	0.00152	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	8.89e-05	0.00148	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	8.89e-05	0.00148	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	8.79e-05	0.00147	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—CHAT—amyotrophic lateral sclerosis	8.73e-05	0.00146	CbGpPWpGaD
Fingolimod—CYP2E1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	8.64e-05	0.00144	CbGpPWpGaD
Fingolimod—CYP2D6—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	8.62e-05	0.00144	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	8.33e-05	0.00139	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	8.32e-05	0.00139	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	8.27e-05	0.00138	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	8.2e-05	0.00137	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	8.1e-05	0.00135	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	8.07e-05	0.00135	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	7.96e-05	0.00133	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	7.89e-05	0.00132	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	7.89e-05	0.00132	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	7.8e-05	0.0013	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	7.8e-05	0.0013	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	7.78e-05	0.0013	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—CHAT—amyotrophic lateral sclerosis	7.5e-05	0.00125	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	7.37e-05	0.00123	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	7.16e-05	0.0012	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	7.14e-05	0.00119	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	7.08e-05	0.00118	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.84e-05	0.00114	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	6.78e-05	0.00113	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	6.59e-05	0.0011	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	6.52e-05	0.00109	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	6.52e-05	0.00109	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	6.35e-05	0.00106	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	6.35e-05	0.00106	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	6.34e-05	0.00106	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	6.27e-05	0.00105	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	6.13e-05	0.00102	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.99e-05	0.000999	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	5.92e-05	0.000988	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.76e-05	0.000962	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.76e-05	0.000962	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	5.76e-05	0.000962	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.57e-05	0.000929	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.46e-05	0.00091	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.43e-05	0.000907	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.36e-05	0.000894	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.36e-05	0.000894	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	5.23e-05	0.000873	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.22e-05	0.000871	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.03e-05	0.000839	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.03e-05	0.000839	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.99e-05	0.000833	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.97e-05	0.00083	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	4.88e-05	0.000815	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.87e-05	0.000812	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.79e-05	0.000799	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.79e-05	0.000799	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.69e-05	0.000783	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.69e-05	0.000782	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.57e-05	0.000762	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.35e-05	0.000725	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.31e-05	0.000719	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.31e-05	0.000719	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.26e-05	0.00071	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—APOE—amyotrophic lateral sclerosis	4.11e-05	0.000685	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.1e-05	0.000684	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.1e-05	0.000684	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.04e-05	0.000674	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.03e-05	0.000672	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	4.01e-05	0.000669	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	4e-05	0.000668	CbGpPWpGaD
Fingolimod—CYP2E1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.87e-05	0.000645	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.85e-05	0.000643	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.85e-05	0.000643	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.85e-05	0.000642	CbGpPWpGaD
Fingolimod—CYP2E1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.82e-05	0.000637	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.72e-05	0.000621	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.7e-05	0.000618	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—APOE—amyotrophic lateral sclerosis	3.55e-05	0.000592	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.54e-05	0.00059	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.5e-05	0.000584	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.41e-05	0.000568	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.41e-05	0.000568	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.29e-05	0.00055	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.29e-05	0.00055	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.17e-05	0.000529	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.17e-05	0.000529	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.1e-05	0.000517	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.09e-05	0.000516	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—APOE—amyotrophic lateral sclerosis	3.05e-05	0.000508	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—VAPB—amyotrophic lateral sclerosis	2.96e-05	0.000495	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—TPK1—amyotrophic lateral sclerosis	2.96e-05	0.000495	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.88e-05	0.00048	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.82e-05	0.00047	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.75e-05	0.000458	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.74e-05	0.000457	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.72e-05	0.000454	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.71e-05	0.000452	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.71e-05	0.000452	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.62e-05	0.000437	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.62e-05	0.000437	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.55e-05	0.000425	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.52e-05	0.000421	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.43e-05	0.000405	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.38e-05	0.000397	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.37e-05	0.000395	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—DAO—amyotrophic lateral sclerosis	2.14e-05	0.000358	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.11e-05	0.000351	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	2.1e-05	0.000351	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	2.1e-05	0.000351	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.09e-05	0.00035	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.09e-05	0.000348	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.02e-05	0.000336	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.02e-05	0.000336	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.98e-05	0.00033	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	1.92e-05	0.000321	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.91e-05	0.000318	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.91e-05	0.000318	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.83e-05	0.000305	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.79e-05	0.000299	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.79e-05	0.000298	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.78e-05	0.000297	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.77e-05	0.000295	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.73e-05	0.000289	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.71e-05	0.000285	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.71e-05	0.000285	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	1.68e-05	0.000281	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.62e-05	0.000271	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.62e-05	0.00027	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.55e-05	0.000259	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.53e-05	0.000256	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	1.52e-05	0.000254	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSR—amyotrophic lateral sclerosis	1.5e-05	0.00025	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	1.38e-05	0.000229	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	1.38e-05	0.000229	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.38e-05	0.000229	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.34e-05	0.000224	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.29e-05	0.000216	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.29e-05	0.000216	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	1.26e-05	0.00021	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.23e-05	0.000205	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.17e-05	0.000196	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.17e-05	0.000195	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.15e-05	0.000192	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	1.1e-05	0.000183	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	1.06e-05	0.000177	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.04e-05	0.000173	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	9.94e-06	0.000166	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	8.73e-06	0.000146	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	7.54e-06	0.000126	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	6.95e-06	0.000116	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.62e-06	0.00011	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.08e-06	0.000101	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	5.71e-06	9.53e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	5e-06	8.35e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.69e-06	7.83e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.31e-06	7.2e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	3.55e-06	5.92e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.43e-06	5.72e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.07e-06	5.12e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.82e-06	4.71e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.43e-06	4.06e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	2.32e-06	3.87e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.59e-06	2.65e-05	CbGpPWpGaD
